Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12243832rdf:typepubmed:Citationlld:pubmed
pubmed-article:12243832lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C0476089lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C0231174lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C0332257lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:12243832lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:12243832pubmed:issue2lld:pubmed
pubmed-article:12243832pubmed:dateCreated2002-9-23lld:pubmed
pubmed-article:12243832pubmed:abstractTextTo evaluate the long-term results of treatment using adjuvant whole abdominal irradiation (WAPI) with a pelvic/vaginal boost in patients with Stage I-III endometrial carcinoma at high risk of intra-abdominopelvic recurrence, including clear cell (CC) and serous-papillary (SP) histologic features.lld:pubmed
pubmed-article:12243832pubmed:languageenglld:pubmed
pubmed-article:12243832pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12243832pubmed:citationSubsetIMlld:pubmed
pubmed-article:12243832pubmed:statusMEDLINElld:pubmed
pubmed-article:12243832pubmed:monthOctlld:pubmed
pubmed-article:12243832pubmed:issn0360-3016lld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:MartinezAlvar...lld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:MitchellChris...lld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:ChenPeterPlld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:WeinerSheldon...lld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:StrombergJann...lld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:StewartKimber...lld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:PodratzKarlKlld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:SchrayMarkMlld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:ShermanAlfred...lld:pubmed
pubmed-article:12243832pubmed:authorpubmed-author:BrabbinsDonal...lld:pubmed
pubmed-article:12243832pubmed:issnTypePrintlld:pubmed
pubmed-article:12243832pubmed:day1lld:pubmed
pubmed-article:12243832pubmed:volume54lld:pubmed
pubmed-article:12243832pubmed:ownerNLMlld:pubmed
pubmed-article:12243832pubmed:authorsCompleteYlld:pubmed
pubmed-article:12243832pubmed:pagination527-35lld:pubmed
pubmed-article:12243832pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:meshHeadingpubmed-meshheading:12243832...lld:pubmed
pubmed-article:12243832pubmed:year2002lld:pubmed
pubmed-article:12243832pubmed:articleTitleTen-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.lld:pubmed
pubmed-article:12243832pubmed:affiliationDepartment of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA.lld:pubmed
pubmed-article:12243832pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12243832pubmed:publicationTypeClinical Triallld:pubmed